ProQR Therapeutics N.V.
PRQR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $182,344 | $129,415 | $208,991 |
| - Cash | $106,883 | $119,765 | $132,414 | $149,408 |
| + Debt | $10,017 | $16,862 | $16,853 | $17,216 |
| Enterprise Value | – | $79,441 | $13,854 | $76,799 |
| Revenue | $2,915 | $3,817 | $4,519 | $4,307 |
| % Growth | -23.6% | -15.5% | 4.9% | – |
| Gross Profit | $2,915 | $3,817 | $4,519 | $4,307 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$10,335 | -$11,574 | -$10,138 | -$5,821 |
| % Margin | -354.5% | -303.2% | -224.3% | -135.2% |
| Net Income | -$11,006 | -$12,179 | -$10,079 | -$9,305 |
| % Margin | -377.6% | -319.1% | -223% | -216% |
| EPS Diluted | -0.1 | -0.12 | -0.1 | -0.11 |
| % Growth | 16.7% | -20% | 9.1% | – |
| Operating Cash Flow | -$12,235 | -$11,401 | -$15,798 | -$9,348 |
| Capital Expenditures | -$169 | -$101 | -$224 | -$133 |
| Free Cash Flow | -$12,404 | -$11,502 | -$16,022 | -$9,481 |